Black Friday Sale! Save huge on InvestingProGet up to 60% off

4 Stocks To Watch: AKAO, CLVS, NRDM, SUPN

Published 01/04/2017, 11:11 PM
Updated 07/09/2023, 06:31 AM
NTRI
-
CF
-
POT
-
FCX
-
CRNT
-
TSEM
-
ARIA
-
ACAD
-
ARRY_old
-
CLVSQ
-
EXAS
-
IMGN
-
KOPN
-
ONTO
-
AGX
-
SGYPQ
-
SUPN
-
OVV
-
BLUE
-
NUGT
-
BIB
-
AERI
-
VUZI
-
AKAOQ
-
JNUG
-
NDRM
-
ONCE_old
-
MB
-
LABU
-
EDIT
-

Achaogen Inc (NASDAQ:AKAO), one of our swing trades, finally popped out of the little coil we were watching, up 1.88, or 14 1/2%, to 14.88, on 2.9 million shares traded on Wednesday. What I’m looking for now is a run up to test 16, and then 19 1/2. Those are my targets going forward.

Clovis Oncology Inc (NASDAQ:CLVS) had a good day on Wednesday. It rebounded from the secondary, up another 1.72, or 4%, to 44.67, on 6.15 million shares traded. After going down to 41.31 to test lower levels, it reversed very nicely. All that’s needed now is for it to take out 46 1/2. It’s on its way to 54-5. My target is 53. It has 6.2 days to cover .

Neuroderm Ltd (NASDAQ:NDRM) is looking good, up 55 cents, or 2.4%, to 23.05, on 114,000 shares traded on Wednesday. It’s up a couple days off of the support level. I’m looking for it to take out the 23 3/4 level, and then run up to 26. That’s my next target.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN) looks good and I love the way it is acting. It went through a double top on Wednesday, up 1.35, or 5.2%, to 27.30, on 646,594 shares traded, closing near the high. That’s the best volume in a couple weeks. I would not be shocked to see this one get up to 33-4.

Stocks on the long side included ACADIA Pharmaceuticals Inc (NASDAQ:ACAD), Direxion Daily S&P Biotech Bull 3X Shares (NYSE:LABU), ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB), Aerie Pharmaceuticals Inc (NASDAQ:AERI), Achaogen Inc, ARIAD Pharmaceuticals Inc (NASDAQ:ARIA), Array BioPharma Inc (NASDAQ:ARRY), Bluebird bio Inc (NASDAQ:BLUE), Clovis Oncology Inc, EXACT Sciences Corporation (NASDAQ:EXAS), ImmunoGen Inc (NASDAQ:IMGN), NeuroDerm Ltd, Spark Therapeutics Inc (NASDAQ:ONCE), Synergy Pharmaceuticals Inc (NASDAQ:SGYP), Supernus Pharmaceuticals Inc, Argan Inc (NYSE:AGX), CF Industries Holdings Inc (NYSE:CF), Potash Corporation of Saskatchewan (NYSE:POT), Ceragon (NASDAQ:CRNT), Encana Corporation (NYSE:ECA), Editas Medicine Inc (NASDAQ:EDIT), Freeport-McMoran Inc (NYSE:FCX), Direxion Daily Jr Gld Mnrs Bull 3X ETF (NYSE:JNUG), Direxion Daily Gold Miners Bull 3X ETF (NYSE:NUGT), Kopin Corporation (NASDAQ:KOPN), Mindbody Inc (NASDAQ:MB), Nanometrics Incorporated (NASDAQ:NANO), NutriSystem Inc (NASDAQ:NTRI), Tower Semiconductor Ltd (NASDAQ:TSEM), Vuzix Corp (NASDAQ:VUZI).

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.